Jiguang Ma

2.8k total citations
52 papers, 2.3k citations indexed

About

Jiguang Ma is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiguang Ma has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Jiguang Ma's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Cells and Metastasis (10 papers) and Hedgehog Signaling Pathway Studies (9 papers). Jiguang Ma is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Cells and Metastasis (10 papers) and Hedgehog Signaling Pathway Studies (9 papers). Jiguang Ma collaborates with scholars based in China and United States. Jiguang Ma's co-authors include Qingyong Ma, Wanxing Duan, Qinhong Xu, Erxi Wu, Xuqi Li, Jianjun Lei, Zhengdong Jiang, Zheng Wang, Weikun Qian and Cancan Zhou and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Annals of the New York Academy of Sciences.

In The Last Decade

Jiguang Ma

52 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiguang Ma China 33 1.2k 910 627 260 230 52 2.3k
Wanxing Duan China 36 1.7k 1.4× 1.3k 1.4× 946 1.5× 316 1.2× 335 1.5× 64 3.1k
Weikun Qian China 24 1.1k 0.9× 589 0.6× 515 0.8× 208 0.8× 238 1.0× 56 1.9k
Qinhong Xu China 36 1.7k 1.4× 1.2k 1.3× 974 1.6× 354 1.4× 343 1.5× 72 3.2k
Zhengdong Jiang China 29 1.2k 0.9× 624 0.7× 626 1.0× 228 0.9× 173 0.8× 51 2.1k
Xianzhong Ding United States 25 794 0.6× 504 0.6× 283 0.5× 380 1.5× 160 0.7× 65 1.9k
Tongyan Liu China 18 851 0.7× 614 0.7× 437 0.7× 262 1.0× 348 1.5× 55 2.0k
Theodoros Tsakiridis Canada 31 2.5k 2.0× 575 0.6× 771 1.2× 602 2.3× 130 0.6× 82 3.5k
Xiuling Zhi China 27 1.1k 0.9× 509 0.6× 399 0.6× 159 0.6× 384 1.7× 63 2.3k
Elżbieta Janda Italy 25 1.4k 1.1× 720 0.8× 239 0.4× 197 0.8× 141 0.6× 40 2.6k
Lev M. Berstein Russia 33 1.7k 1.4× 1.1k 1.2× 971 1.5× 340 1.3× 136 0.6× 103 3.6k

Countries citing papers authored by Jiguang Ma

Since Specialization
Citations

This map shows the geographic impact of Jiguang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiguang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiguang Ma more than expected).

Fields of papers citing papers by Jiguang Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiguang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiguang Ma. The network helps show where Jiguang Ma may publish in the future.

Co-authorship network of co-authors of Jiguang Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Jiguang Ma. A scholar is included among the top collaborators of Jiguang Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiguang Ma. Jiguang Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Xin, Liang Sheng, Jiguang Ma, et al.. (2021). 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone provokes progression from chronic pancreatitis to pancreatic intraepithelial neoplasia. iScience. 25(1). 103647–103647. 3 indexed citations
3.
Xiao, Ying, Tao Qin, Liankang Sun, et al.. (2020). Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation. Cell Transplantation. 29. 2790872646–2790872646. 35 indexed citations
4.
Han, Liang, Weikun Qian, Jie Li, et al.. (2020). Nitric Oxide Stimulates Acute Pancreatitis Pain via Activating the NF-κB Signaling Pathway and Inhibiting the Kappa Opioid Receptor. Oxidative Medicine and Cellular Longevity. 2020. 1–13. 13 indexed citations
5.
Qian, Weikun, Lin Wang, Tao Qin, et al.. (2020). Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation. Biomedicine & Pharmacotherapy. 127. 110116–110116. 35 indexed citations
6.
Nan, Ligang, Tao Qin, Ying Xiao, et al.. (2019). Pancreatic Stellate Cells Facilitate Perineural Invasion of Pancreatic Cancer via HGF/c-Met Pathway. Cell Transplantation. 28(9-10). 1289–1298. 36 indexed citations
7.
Zhou, Cancan, Weikun Qian, Jie Li, et al.. (2019). High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 302–302. 79 indexed citations
8.
Yan, Bin, Liang Cheng, Zhengdong Jiang, et al.. (2018). Resveratrol Inhibits ROS‐Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR‐21. Oxidative Medicine and Cellular Longevity. 2018(1). 1346958–1346958. 61 indexed citations
9.
Cheng, Liang, Bin Yan, Ke Chen, et al.. (2018). Resveratrol‐Induced Downregulation of NAF‐1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2018(1). 9482018–9482018. 69 indexed citations
11.
Jiang, Zhengdong, Cancan Zhou, Liang Cheng, et al.. (2018). Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions. Journal of Experimental & Clinical Cancer Research. 37(1). 69–69. 60 indexed citations
12.
Zhang, Lun, Jiahui Li, Jiguang Ma, et al.. (2015). The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. Oxidative Medicine and Cellular Longevity. 2016(1). 3897250–3897250. 28 indexed citations
13.
Li, Junhui, Jiguang Ma, Liang Han, et al.. (2015). Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer. Cancer Biology & Therapy. 16(6). 912–921. 31 indexed citations
14.
Ma, Jiguang, Wanxing Duan, Suxia Han, et al.. (2015). Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Oncotarget. 6(25). 20993–21003. 74 indexed citations
15.
Li, Xuqi, Zheng Wang, Qingyong Ma, et al.. (2014). Sonic Hedgehog Paracrine Signaling Activates Stromal Cells to Promote Perineural Invasion in Pancreatic Cancer. Clinical Cancer Research. 20(16). 4326–4338. 131 indexed citations
17.
Xu, Jun, Wěi Li, Jiguang Ma, et al.. (2013). Vitamin D - Pivotal Nutraceutical in the Regulation of Cancer Metastasis and Angiogenesis. Current Medicinal Chemistry. 20(33). 4109–4120. 18 indexed citations
18.
Lei, Jianjun, Jiguang Ma, Qingyong Ma, et al.. (2013). Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Molecular Cancer. 12(1). 66–66. 133 indexed citations
19.
Ma, Jiguang, Zhenhua Ma, Wěi Li, et al.. (2013). The Mechanism of Calcitriol in Cancer Prevention and Treatment. Current Medicinal Chemistry. 20(33). 4121–4130. 6 indexed citations
20.
Ma, Jiguang, et al.. (2011). [Comparison of biological behavior between triple-negative breast cancer and non-triple- negative breast cancer].. PubMed. 31(10). 1729–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026